Log In
Print
BCIQ
Print
Print this Print this
 

Vfend, voriconazole

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionTriazole ergosterol synthesis inhibitor
Molecular Target Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of ActionCytochrome P450 C-14 alpha demethylase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today